Meiwu Technology Co., Ltd. (NASDAQ: WNW) announced on December 3 2025 that it had signed a non‑binding Memorandum of Understanding with Real BioTech (Qingdao) Ltd., a marine biotechnology company headquartered in Qingdao, China. The MOU, signed on November 25 2025, outlines a collaboration to develop beauty solutions that incorporate marine active ingredients.
The partnership marks a key milestone in Meiwu’s broader strategy to pivot from its original Clean Food platform toward the high‑growth skincare sector. By integrating marine biotechnology into its beauty portfolio, Meiwu aims to differentiate itself in China’s crowded e‑commerce beauty market and capture new market share.
Real BioTech is a leading marine biomedical materials firm known for its fish‑scale glue technology and a portfolio of marine‑derived ingredients used in functional food, cosmetics, and medical devices. Its R&D capabilities are expected to provide Meiwu with access to proprietary marine compounds that can be formulated into science‑backed skincare products.
Under the MOU, Meiwu will receive R&D support, technical services, and consulting from Real BioTech, while Real BioTech will gain access to Meiwu’s established brand operations and distribution network. The collaboration is designed to accelerate product development, expand Meiwu’s product line, and strengthen its competitive position in the beauty e‑commerce space.
The announcement was well received by investors, with analysts noting the strategic fit between Meiwu’s distribution strengths and Real BioTech’s marine biotechnology expertise. The partnership is expected to enhance Meiwu’s growth prospects in the skincare market, although the company’s recent financial volatility and Nasdaq compliance challenges remain a backdrop to the deal.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.